AZ-话题@MedSci

#AZ#

260篇内容 | 4199人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1714858, encodeId=23e91e148587e, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=TAZVERIK（tazemetostat）治疗滤泡性淋巴瘤：FDA已批准其NDA, objectType=article, longId=188196, objectId=741e188196b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=741e188196b9, replyNumber=0, likeNumber=81, createdTime=2020-05-12, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=741e188196b9, moduleTitle=TAZVERIK（tazemetostat）治疗滤泡性淋巴瘤：FDA已批准其NDA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=741e188196b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714854, encodeId=17281e14854bd, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=TAZVERIK（Tazemetostat）已获批准用于治疗上皮样肉瘤, objectType=article, longId=186735, objectId=a745186e35dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a745186e35dc, replyNumber=0, likeNumber=60, createdTime=2020-08-27, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a745186e35dc, moduleTitle=TAZVERIK（Tazemetostat）已获批准用于治疗上皮样肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a745186e35dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714867, encodeId=04711e148670d, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, objectType=article, longId=192727, objectId=297f192e2779, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=297f192e2779, replyNumber=0, likeNumber=66, createdTime=2021-03-13, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=297f192e2779, moduleTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=297f192e2779)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714879, encodeId=1ae31e148795e, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Phys Ther：孕期运动可预防孕产妇体重增长过快和妊娠糖尿病, objectType=article, longId=196669, objectId=1c72196669b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c72196669b4, replyNumber=0, likeNumber=73, createdTime=2020-07-04, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c72196669b4, moduleTitle=Braz J Phys Ther：孕期运动可预防孕产妇体重增长过快和妊娠糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c72196669b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714876, encodeId=eb011e1487626, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Oral Res：多西环素封装在β-环糊精中可用于治疗牙周炎, objectType=article, longId=196394, objectId=c5dd1963949b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5dd1963949b, replyNumber=0, likeNumber=78, createdTime=2020-07-08, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5dd1963949b, moduleTitle=Braz Oral Res：多西环素封装在β-环糊精中可用于治疗牙周炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5dd1963949b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714844, encodeId=2cc51e148448f, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Endod：Gow-Gates, Vazirani-Akinosi和Mental Incisive神经阻滞对有症状不可逆牙髓炎的麻醉效果比较, objectType=article, longId=180412, objectId=e63e18041230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e63e18041230, replyNumber=0, likeNumber=61, createdTime=2019-10-21, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e63e18041230, moduleTitle=J Endod：Gow-Gates, Vazirani-Akinosi和Mental Incisive神经阻滞对有症状不可逆牙髓炎的麻醉效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e63e18041230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714884, encodeId=827f1e148842e, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Otorhinolaryngol：突发感音神经性耳聋中不良预后的预测参数研究 , objectType=article, longId=199760, objectId=25fc199e6001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25fc199e6001, replyNumber=0, likeNumber=77, createdTime=2021-04-21, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25fc199e6001, moduleTitle=Braz J Otorhinolaryngol：突发感音神经性耳聋中不良预后的预测参数研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25fc199e6001)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714870, encodeId=94371e1487003, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Otorhinolaryngol：特纳综合征患者的听力情况与细胞遗传改变相关性分析, objectType=article, longId=194435, objectId=43d7194435c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43d7194435c8, replyNumber=0, likeNumber=53, createdTime=2020-10-18, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43d7194435c8, moduleTitle=Braz J Otorhinolaryngol：特纳综合征患者的听力情况与细胞遗传改变相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43d7194435c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714849, encodeId=db561e1484948, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=AZ/Daiichi的乳腺癌曲妥珠抗体偶联药物ADC获得美国优先审查, objectType=article, longId=181535, objectId=7549181535e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7549181535e0, replyNumber=0, likeNumber=87, createdTime=2020-09-09, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7549181535e0, moduleTitle=AZ/Daiichi的乳腺癌曲妥珠抗体偶联药物ADC获得美国优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7549181535e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714869, encodeId=10751e1486928, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=女性滴虫病的治疗：Solosec®（secnidazole）的III期临床取得积极结果, objectType=article, longId=193524, objectId=6f49193524a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f49193524a1, replyNumber=0, likeNumber=48, createdTime=2020-09-03, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f49193524a1, moduleTitle=女性滴虫病的治疗：Solosec®（secnidazole）的III期临床取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f49193524a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714873, encodeId=c2c31e148739e, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Orphazyme的热休克蛋白疗法Arimoclomol治疗肌萎缩性侧索硬化症，获得美国快速通道指定, objectType=article, longId=194612, objectId=340c19461254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=340c19461254, replyNumber=0, likeNumber=73, createdTime=2020-07-25, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=340c19461254, moduleTitle=Orphazyme的热休克蛋白疗法Arimoclomol治疗肌萎缩性侧索硬化症，获得美国快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=340c19461254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714839, encodeId=fb4f1e1483987, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Saroglitazar Magnesium治疗2型糖尿病的III期试验取得积极结果, objectType=article, longId=176832, objectId=b5881e683297, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5881e683297, replyNumber=0, likeNumber=77, createdTime=2019-11-25, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5881e683297, moduleTitle=Saroglitazar Magnesium治疗2型糖尿病的III期试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5881e683297)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714856, encodeId=27a61e148561d, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Pulmatrix的吸入式抗真菌药Pulmazole获得FDA的快速通道指定，用于治疗哮喘患者的过敏性支气管肺曲霉病, objectType=article, longId=187170, objectId=62cd18e17067, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cd18e17067, replyNumber=0, likeNumber=48, createdTime=2020-06-13, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cd18e17067, moduleTitle=Pulmatrix的吸入式抗真菌药Pulmazole获得FDA的快速通道指定，用于治疗哮喘患者的过敏性支气管肺曲霉病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cd18e17067)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714861, encodeId=908b1e14861f7, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Cardiovasc Surg：轻度术前肾功能不全患者冠状动脉搭桥术后的结果, objectType=article, longId=189152, objectId=cc1d189152fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d189152fb, replyNumber=0, likeNumber=61, createdTime=2020-10-28, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d189152fb, moduleTitle=Braz J Cardiovasc Surg：轻度术前肾功能不全患者冠状动脉搭桥术后的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d189152fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714865, encodeId=0d8a1e14865ff, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Dent J：手术及非手术治疗侵袭性牙周炎的临床和微生物学评估, objectType=article, longId=192545, objectId=c32219254583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c32219254583, replyNumber=0, likeNumber=85, createdTime=2021-02-18, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c32219254583, moduleTitle=Braz Dent J：手术及非手术治疗侵袭性牙周炎的临床和微生物学评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c32219254583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714843, encodeId=693f1e148432e, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定, objectType=article, longId=179673, objectId=1fca1e96732d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fca1e96732d, replyNumber=0, likeNumber=58, createdTime=2019-12-21, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fca1e96732d, moduleTitle=FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fca1e96732d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714846, encodeId=a5161e14846ac, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Oral Res：甲硝唑和阿莫西林全身辅助使用在非手术治疗种植体周围炎的效果, objectType=article, longId=181190, objectId=338e18119006, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=338e18119006, replyNumber=0, likeNumber=91, createdTime=2019-10-25, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=338e18119006, moduleTitle=Braz Oral Res：甲硝唑和阿莫西林全身辅助使用在非手术治疗种植体周围炎的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=338e18119006)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714834, encodeId=72a41e148348c, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=FDA批准Emflaza治疗年轻DMD患者, objectType=article, longId=168071, objectId=6ea81680e175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea81680e175, replyNumber=0, likeNumber=97, createdTime=2019-11-09, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea81680e175, moduleTitle=FDA批准Emflaza治疗年轻DMD患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea81680e175)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714840, encodeId=39851e1484092, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=AZ的SGLT2抑制剂Forxiga在欧盟扩展用于II型糖尿病, objectType=article, longId=177009, objectId=bd4e1e700904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd4e1e700904, replyNumber=0, likeNumber=125, createdTime=2020-07-05, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd4e1e700904, moduleTitle=AZ的SGLT2抑制剂Forxiga在欧盟扩展用于II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd4e1e700904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714847, encodeId=a0c51e1484752, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Oral Res：糖尿病/高糖与种植体周围炎的高发病风险相关, objectType=article, longId=181192, objectId=b6fe1811926a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6fe1811926a, replyNumber=0, likeNumber=57, createdTime=2019-11-19, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6fe1811926a, moduleTitle=Braz Oral Res：糖尿病/高糖与种植体周围炎的高发病风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6fe1811926a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

AZ

2020-05-29

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

TAZVERIK（tazemetostat）治疗滤泡性淋巴瘤：FDA已批准其NDA

2020-05-12

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

TAZVERIK（Tazemetostat）已获批准用于治疗上皮样肉瘤

2020-08-27

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性

2021-03-13

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Phys Ther：孕期运动可预防孕产妇体重增长过快和妊娠糖尿病

2020-07-04

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Oral Res：多西环素封装在β-环糊精中可用于治疗牙周炎

2020-07-08

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Endod：Gow-Gates, Vazirani-Akinosi和Mental Incisive神经阻滞对有症状不可逆牙髓炎的麻醉效果比较

2019-10-21

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Otorhinolaryngol：突发感音神经性耳聋中不良预后的预测参数研究

2021-04-21

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Otorhinolaryngol：特纳综合征患者的听力情况与细胞遗传改变相关性分析

2020-10-18

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

AZ/Daiichi的乳腺癌曲妥珠抗体偶联药物ADC获得美国优先审查

2020-09-09

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

女性滴虫病的治疗：Solosec®（secnidazole）的III期临床取得积极结果

2020-09-03

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Orphazyme的热休克蛋白疗法Arimoclomol治疗肌萎缩性侧索硬化症，获得美国快速通道指定

2020-07-25

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Saroglitazar Magnesium治疗2型糖尿病的III期试验取得积极结果

2019-11-25

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Pulmatrix的吸入式抗真菌药Pulmazole获得FDA的快速通道指定，用于治疗哮喘患者的过敏性支气管肺曲霉病

2020-06-13

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Cardiovasc Surg：轻度术前肾功能不全患者冠状动脉搭桥术后的结果

2020-10-28

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Dent J：手术及非手术治疗侵袭性牙周炎的临床和微生物学评估

2021-02-18

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定

2019-12-21

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Oral Res：甲硝唑和阿莫西林全身辅助使用在非手术治疗种植体周围炎的效果

2019-10-25

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

FDA批准Emflaza治疗年轻DMD患者

2019-11-09

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

AZ的SGLT2抑制剂Forxiga在欧盟扩展用于II型糖尿病

2020-07-05

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Oral Res：糖尿病/高糖与种植体周围炎的高发病风险相关

2019-11-19

科室
- - 订阅+
  - 更多科室
工具
服务